M. C. Berenbaum

7.5k total citations · 4 hit papers
100 papers, 6.1k citations indexed

About

M. C. Berenbaum is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, M. C. Berenbaum has authored 100 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 25 papers in Pulmonary and Respiratory Medicine and 19 papers in Immunology. Recurrent topics in M. C. Berenbaum's work include Photodynamic Therapy Research Studies (19 papers), Porphyrin and Phthalocyanine Chemistry (10 papers) and Effects of Radiation Exposure (7 papers). M. C. Berenbaum is often cited by papers focused on Photodynamic Therapy Research Studies (19 papers), Porphyrin and Phthalocyanine Chemistry (10 papers) and Effects of Radiation Exposure (7 papers). M. C. Berenbaum collaborates with scholars based in United Kingdom, South Africa and United States. M. C. Berenbaum's co-authors include Raymond Bonnett, Ralph Devere White, P. R. Riddle, Panayiotis A. Scourides, I.N. Brown, Laurence M. Black, John F. Kelly, M. E. SNELL, Theodore X. O'Connell and Geert H. M. Gijsbers and has published in prestigious journals such as Nature, The Lancet and Blood.

In The Last Decade

M. C. Berenbaum

96 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

What is synergy?

1989 1.2k citations M. C. Berenbaum profile →
A Method for Testing for Synergy with Any Number of Agents

1978 616 citations M. C. Berenbaum profile →
The expected effect of a combination of agents: the general solution

1985 419 citations M. C. Berenbaum profile →
Criteria for Analyzing Interactions between Biologically Active Agents

1981 390 citations M. C. Berenbaum profile →

Peers

Countries citing papers authored by M. C. Berenbaum

Since Specialization

Citations

This map shows the geographic impact of M. C. Berenbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. C. Berenbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. C. Berenbaum more than expected).

Fields of papers citing papers by M. C. Berenbaum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. C. Berenbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. C. Berenbaum. The network helps show where M. C. Berenbaum may publish in the future.

Co-authorship network of co-authors of M. C. Berenbaum

This figure shows the co-authorship network connecting the top 25 collaborators of M. C. Berenbaum. A scholar is included among the top collaborators of M. C. Berenbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. C. Berenbaum. M. C. Berenbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Porphyrins as Photosensitizers 2007 ·Novartis Foundation symposium ·Raymond Bonnett, M. C. Berenbaum	23
2	Protective Effects of a Novel Perfluorochemical Emulsion in Photodynamic Therapy 1992 ·Biomaterials Artificial Cells and Immobilization Biotechnology ·K. C. Lowe, (unknown), Raymond Bonnett, Ralph Devere White, M. C. Berenbaum	7
3	Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical results 1991 ·British Journal of Cancer ·Hans‐Beat Ris, H. J. Altermatt, Rolf Inderbitzi, Rachel Hess, B Nachbur, J. C. M. Stewart, (unknown), (unknown), Raymond Bonnett, M. C. Berenbaum	196
4	Perfluorochemicals and Photodynamic Therapy in Mice 1990 ·Advances in experimental medicine and biology ·M. C. Berenbaum, (unknown), (unknown), P. Bentley, Raymond Bonnett, Ralph Devere White, K. C. Lowe	7
5	Porphyrin sensitizers in tumour phototherapy. Novel sensitizers of the chlorin and bacteriochlorin class with amphiphilic properties 1990 ·Journal of Photochemistry and Photobiology B Biology ·Raymond Bonnett, (unknown), (unknown), M. C. Berenbaum	35
6	Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumour photosensitizers 1989 ·Biochemical Journal ·Raymond Bonnett, Ralph Devere White, (unknown), M. C. Berenbaum	281
7	The Rabbit VX2 Tumour as a Model for Carcinomas of the Tongue and Larynx 1989 ·Acta Oto-Laryngologica ·(unknown), M. C. Berenbaum	16
8	Cerebral photosensitisation by haematoporphyrin derivative. Evidence for an endothelial site of action 1986 ·British Journal of Cancer ·M. C. Berenbaum, Georgina Hall, A D Hoyes	89
9	Cell Culture Methods for Molecular and Cell Biology 1985 ·Journal of the Royal Society of Medicine ·M. C. Berenbaum	148
10	Wavelength and light-dose dependence in tumour phototheraphy with haematoporphyrin derivative 1985 ·British Journal of Cancer ·(unknown), M. C. Berenbaum, Geert H. M. Gijsbers	94
11	Increased therapeutic efficiency of a lipid-soluble alkylating agent incorporated in liposomes 1982 ·British Journal of Cancer ·(unknown), M. C. Berenbaum	4
12	The Use of Alternatives in Drug Research 1981 ·Immunology ·M. C. Berenbaum	2
13	The Growth of Human Tumours in Immunosuppressed Mice and Their Response to Chemotherapy 1974 ·British Journal of Cancer ·M. C. Berenbaum, (unknown), (unknown), R V Bundick	38
14	TESTING ANTI-CANCER DRUGS 1972 ·The Lancet ·C. N. Hudson, M. C. Berenbaum, (unknown)	1
15	Effect of L-Asparaginase on Germinal Centre Haemolysin 1971 ·Nature ·M. C. Berenbaum, (unknown)	2
16	Dose-response curves for agents that impair cell reproductive integrity. A fundamental difference between dose-response curves or antimetabolites and those for radiation and alkylating agents. 1969 ·British Journal of Cancer ·M. C. Berenbaum	16
17	POSTOPERATIVE DEPRESSION OF THE LYMPHOCYTE RESPONSE TO PHYTOHÆMAGGLUTININ 1967 ·The Lancet ·P. R. Riddle, M. C. Berenbaum	151
18	EFFECTS OF CARCINOGENS ON IMMUNE PROCESSES 1964 ·British Medical Bulletin ·M. C. Berenbaum	36
19	PROLONGATION OF HOMOGRAFT SURVIVAL IN GUINEA-PIGS 1964 ·Transplantation ·M. C. Berenbaum	3
20	TUBAL PREGNANCY IN TUBERCULOUS SALPINGITIS* 1954 ·BJOG An International Journal of Obstetrics & Gynaecology ·M. C. Berenbaum, (unknown)	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact